ABSTRACT. We studied the numbers of T-cell receptor alb-and 716-bearing lymphocytes in 27 jejunal specimens from 19 celiac patients, 27 rectal and colonic specimens from 14 ulcerative colitis patients and four patients with Crohn's disease, and 24 control specimens. MAb and a three-layer peroxidase staining method were used. Only low numbers of 7/6+ cells were seen in normal jejunum and rectum of controls, as well as in the specimens of patients with inflammatory bowel diseases. In the lamina propria of celiac patients, the mean number of 7/6+ cells was significantly higher than in the controls before treatment, during gluten-free diet, and after the gluten challenge. Within the jejunal epithelium, the number of 7/6+ cells was elevated before and during gluten elimination and after the challenge test. The absolute number of intraepithelial 7/6+ cells remained constant during gluten elimination and provocation. We infer that the constantly elevated population of y/6+ T cells in the epithelium of celiac patients may play an important role in the pathogenesis of celiac disease. (Pediatv Res 28: 579-581, 1990) 
The intestinal IEL are a cell population whose significance in the immune defenses is presently unknown (1) . The majority of IEL are CD3+ T cells, more than 90% of which express the surface CD8 antigen, with very few showing the CD4 antigen in normal human jejunal mucosa (2, 3) . In patients with celiac disease, a considerable proportion of jejunal CD3+ IEL express neither the CD8 nor the CD4 antigen (2) (3) (4) , suggesting that they might bear TCR 716. In the normal human intestine, less than 10% of lymphocytes bear y/6 TCR (5-8), as is the case in peripheral blood (9) . In the intestine of patients with active celiac disease, the population of TCR y/6-bearing lymphocytes seems to be distinctly increased, particularly in the epithelium (6, 10) .
We measured the total number of TCR-y/F+ cells and alp+ lymphocytes in the normal jejunum and in the jejunum of patients with celiac disease. Particularly in the epithelium, but also in the lamina propria of celiacs, there was a constantly increased number of 7/6+ cells regardless of dietary treatment and jejunal morphology. This finding is the only permanent abnormality described thus far in the jejunal mucosa of patients with celiac disease.
MATERIALS A N D METHODS
Patients. Twenty-five jejunal specimens from 19 pediatric patients with celiac disease were used in this study; nine were taken before treatment at a mean age of 5.3 y, eight were taken during GFD (12.1 y), and eight after a gluten challenge resulting in villous atrophy (12.2 y). From six patients, the specimens both during gluten elimination and after the gluten challenge were available. As controls, we studied 13 histologically normal jejunal specimens taken from children at a mean age of 8.2 y as a part of the evaluation of their asymptomatic growth failure. As a disease control, a jejunal biopsy specimen showing total villous atrophy from a 16-mo-old patient with multiple food allergies was studied. This patient had never had gluten-containing foods. A detailed study of lymphocytes bearing surface antigens CD3, CD4, and CD8 in the lamina propria and epithelium of the jejunum of these patients has been reported earlier (3) .
Rectal biopsy specimens of 14 children (mean age 1 1.2 y) with ulcerative colitis were taken before any treatment and part of them were used for our study. From seven of the patients, a specimen from the sigmoid colon taken during colonoscopy was also available. Four rectal and two colonic specimens from four patients with Crohn's disease were also studied. All specimens showed inflammatory changes. As controls, we used parts of specimens taken from 10 neurologic patients (1 1).
Our study protocol was reviewed and approved by the Ethical Committee of Children's Hospital, University of Helsinki.
Tissue processing. The biopsy specimens were freshly embedded in OCT compound and stored at -70°C. Five-Fm cryostat serial sections were fixed in acetone for 10 min, then in chloroform for 30 min, and washed three times in Tris buffer pH 7.4.
Zmmunohistochemical staining. After removing the buffer, sections were covered with the diluted MAb in Tris buffer for 16 h. Endogenous peroxidase was blocked by incubation in 0.5% peroxidase for 30 min. To stain MAb, a Vectastain Elite ABC kit (PK-6 102, Vectro Laboratories, Burlinghame, CA) was used according to the instructions of the manufacturer.
Positively stained cells were counted with a light microscope using 900x magnification (3, 1 I).
MAb. MAb TCRdeltal (T cell Sciences Inc., Cambridge, MA), recognizing constant region of 6-chain of TCR (12, 13) and all y/6+ cells (5, 14) , and antibody betaF1, reacting with virtually all a l p TCR molecules (14) , were used in dilution 1: 100. MAb Leu4 (anti-CD3, Beckton-Dickinson, Mountain View, CA) was used in dilution 1 :400.
Statistical analysis. The numbers of cells in the study specimens were compared with those of the controls using t test. A paired t test was used to compare cell numbers of celiac patients before and after the gluten challenge. junum. In the morphologically normal intestine of the controls, the great majority of T cells expressed LYIP TCR; 7/6+ cells were DISCUSSION scarce and their mean proportion of the CD3+ cells was 5.5% (Fig. I) . The density and proportion of 7/6+ cells was signifiOur findings confirm the earlier observations of low numbers cantly higher in the lamina propria of the jejunal specimens of TCR 7/6+ cells both intraepithelially and in the lamina taken from celiac patients before treatment (1 5% of CD3+ cells), propria of normal human intestine (5-7), and increased numbers during GFD (1 3%), and after the gluten challenge (14%) (Fig. 1 ) in active celiac disease (6, 10). Our main findings are the conthan in the controls; their density was not affected by gluten stantly elevated numbers of both intraepithelial and lamina challenge or gluten elimination.
propria 716 TCR+ cells in celiacs, regardless of dietary treatment TCR 716-bearing lymphocytes in jejunal epithelium. The mean and jejunal morphology. This increase was not seen in five number of 7/6+ cells was 3.5 cells/mm in the surface epithelium patients with tropical sprue (6) , nor in a case with total villous of the control children with a normal jejunum (Fig. 2) . In the atrophy and food allergy in our study.
specimen of the patient with total villous atrophy and food
In striking contrast to the constant increase of 7/6+ cells in allergy, the number of 7/6+ cells was 1.6/mm of surface epithe-the jejunal mucosa of celiac patients, the inflamed specimens lium.
from patients with inflammatory bowel diseases did not differ In celiacs, the numbers of 7/6+ cells were increased in the from the controls in this respect. This suggests that the observed surface epithelium before treatment, during the GFD, and after increase in y/6+ cells is not linked with a tendency to inflamthe gluten challenge as compared with controls (Figs. 2 and 3) . mation in general, but may be specific of celiac disease.
In the surface epithelium, 7/6+ cells composed 32% of CD3+
The primary event in celiac disease is most likely the increased cells before the treatment, 62% during the GFD, and 29% after rate of destruction of epithelial cells, when the patient is eating the gluten challenge. In the jejunal specimens of all patients, the foods containing gluten. IEL may be effectors in this process. mean number of y/6+ cells was unchanged at different phases TCR 716-bearing cells can exert non-major histocompatibility of the treatment of celiac disease in the epithelium (Fig. 2) . This complex-restricted cytolytic activity against tumor cells (15) (16) , could be further corroborated in the six celiac patients followed and also toward IgG Fc receptor-bearing target cells (17) when through gluten challenge test (Fig. 4) .
first activated with MAb to CD3. It may be speculated that if y l TCR 716-bearing lymphocytes in rectum and colon. The num-6+ cells are stimulated by fractions of gluten or intraluminal bers of 7/6+ cells in the rectal and colonic lamina propria of microbial antigens, they may become cytotoxic to the epithelial patients with inflammatory bowel disease did not differ from cells possibly altered by adhering gluten fractions or fixed Ig. On those in the controls (Table 1) . Within the epithelium, no 7/6+ the other hand, the increase of 7/6+ cells may be associated with cells were seen in the majority of specimens, regardless of the the human leukocyte antigen D region linked genetic immune diagnostic group (Table I) .
abnormality shared by celiac disease and dermatitis herpetiformis 
Controls Rectum
Number of Lamina propria Surface specimens (cells/mm2) epithelium *In the positive specimens, the cell density for lamina propria was >10/mm2; for surface epithelium, >0.5/mm. For lamina propria, the mean and SEM for the cell density are given in parentheses. (18) , in which case the y/6+ cells might play no role in the pathogenesis of villous atrophy of celiac disease. This is advocated by the absence of y/6+ cells in other forms of diseases with villous atrophy, as shown in patients with tropical sprue (6) and in the food allergy case of this study, and by their abundance in morphologically normal jejunal specimens of patients with dermatitis herpetiformis on a normal gluten-containing diet (19) . The measurement of y/6+ cells may also prove a valuable diagnostic tool in differentiation of celiac disease from other forms of villous atrophy; however, more experience is needed. The permanence of the increase may allow the identification of a celiac patient also when the biopsy is taken on a GFD and other morphologic signs are normalized.
